Perspectives on Enquiry & Evidence
Cytel's blog featuring the latest industry insights.
September 4, 2015
Our Client's Challenge: Can knowledge of the relationship between biomarkers and clinical endpoints help us to optimize...
Read article
August 10, 2015
Mitigate Phase 3 Clinical Trial Risk by Optimizing Phase 2 Data
When approaching a Phase 3 clinical trial, the need to ‘de-risk’ the massive investment often leads sponsors on a quest...
Read article
January 22, 2015
Adaptive Clinical Trial Strategies for the Limited Early Phase Budget
The Journal of the American Medical Association recently published an article entitled ‘The Anatomy of Medical...
Read article